The earliest stages of lead discovery usually focus on obtaining a molecule with decent affinity for a given target. Affinity, or binding energy, can be dissected into two components: enthalpy and entropy. On a (very) simplistic level, enthalpic binding comes via specific molecular interactions, such as hydrogen bonds, while entropic binding results from nonspecific hydrophobic interactions. Optimizing enthalpy is usually more difficult than optimizing entropy: engineering a polar interaction requires more precision than adding a bit of grease. In a new paper in ChemMedChem, Andrew Scott and colleagues at Pfizer show how fragments that owe more of their binding affinity to enthalpy make better starting points for optimization than do fragments whose binding is more entropic, even if the entropic fragment is more potent.
The researchers used human carbonic anhydrase (hCA II), a venerable work-horse of biophysical studies. Benzenesulfonamide (compound 1, below) is a known binder, and the researchers studied the thermodynamics of 20 derivatives of this molecule using isothermal titration calorimetry (ITC), taking care to generate high-quality binding data. Adding a fluorine group to the 2-position of benzenesulfonamide (compound 2) improves the potency almost three-fold but lowers the ligand efficiency. In contrast, adding a fluorine to the 3-position (compound 3) improves the potency by seven-fold and also improves the ligand efficiency.
If you were choosing between these fragments solely on the basis of affinity or ligand efficiency, it would be reasonable to choose compound 3, and in fact a search of the literature turned up 15 carbonic anhydrase inhibitors that contained the 3-fluorobenzenesulfonamide substructure and none that contained the 2-flurobenzenesulfonamide substructure. However, a look at the thermodynamic parameters reveals that the affinity of compound 2 is driven by a sizable improvement in enthalpic binding, partially offset by lowered entropy. In contrast, compound 3 has a similar enthalpy of binding as compound 1 but increased entropy. What’s going on?
The researchers determined high-resolution crystal structures for all three of these molecules bound to hCA II. Interestingly, the structure of compound 2 shows a specific interaction between the fluorine atom and a main-chain NH of the protein. In compound 3, the fluorine points towards the hydrophobic wall of the protein.
Adding a 4-benzylamide substituent onto each of these molecules led to improvements in activity. However, this was a relatively modest boost for the more entropic compound 3 to compound 20, but considerably larger for the enthaplically-driven compound 2 to compound 19. Compound 19 shows a highly favorable binding enthalpy, and is the most potent and ligand-efficient of any of the three elaborated molecules.
Obtaining thermodynamic parameters for small-molecule protein interactions has historically been challenging, but in recent years miniaturization and improvements in technology have brought ITC into more non-specialist labs. If you have the resources, it may be worthwhile characterizing the thermodynamic profiles of your fragment hits, and – perhaps – looking more closely at those that show enthalpically-driven binding.
1 comment:
How to explain the fact that Compound 1, which has the same enthalpy as Compound 3, resulted in larger improvement of affinity compared to Compound 3?
Perhaps the position of the fluorine group might be affecting the lowest energy conformations of the molecule. Those molecules with lowest energy conformations resembling the bound-like conformation should present higher affinities (ignoring everything else).
The data on this paper show a typical feature of difficult optimization problems. That is, the best solution (molecule) may not be derived by individually optimizing partial solutions (fragments). Thus one need to consider suboptimal fragments as well.
Post a Comment